| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51,402 | 57,465 | 69,704 | 99,973 | | Cost of Revenue | (63,244) | 39,127 | 48,092 | 75,085 | | | Gross Profit | 114,646 | 18,338 | 21,612 | 24,888 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 100,449 | 6,675 | 6,667 | 9,819 | | Non Recurring |
-
|
-
| 120,920 |
-
| | Others | 8,047 | 8,978 | 10,111 | 11,741 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,150 | 2,685 | (116,086) | 3,328 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 150 | (2,350) | 155 | 240 | | Earnings Before Interest And Taxes | 6,296 | 337 | (115,925) | 3,572 | | Interest Expense | 5,071 | 5,595 | 6,025 | 6,464 | | Income Before Tax | 1,225 | (5,258) | (121,950) | (2,892) | | Income Tax Expense | (231) | (2,208) | (19,626) | (1,387) | | Minority Interest | 32,633 |
-
|
-
| 463 | | | | Net Income From Continuing Ops | 31,592 | (3,050) | (102,324) | (1,042) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,089 | (3,050) | (102,324) | (1,042) | | Preferred Stock And Other Adjustments | (32,841) | 735 | 32,106 |
-
| | | Net Income Applicable To Common Shares | $1,248 | ($2,315) | ($70,218) | ($1,042) |
|
0.51% Nasdaq 
Income Statement
